Publicação: 1.39 - Intestinal Dysbiosis in Autoimmune Diseases
dc.contributor.author | de Oliveira, Gislane Lelis Vilela [UNESP] | |
dc.contributor.institution | Humanities and Exact Sciences | |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
dc.date.accessioned | 2023-07-29T13:06:43Z | |
dc.date.available | 2023-07-29T13:06:43Z | |
dc.date.issued | 2022-01-01 | |
dc.description.abstract | Evidence from animal models and humans suggests the role of intestinal dysbiosis in autoimmune disease development. Dysbiosis is associated with decreased microbiota function and diversity, increased intestinal permeability and pathobionts, and deregulated immune response. The proposed mechanisms to connect dysbiosis with autoimmunity include molecular mimicry, bystander T-cell activation, epitope spreading, post-translational modification of luminal proteins, and amplification by inflammatory cytokines. Probiotic bacteria favor the balance and maintenance of a healthy microbiota and epithelial barrier and directly impact systemic immunity, supporting their use in immune-mediated diseases. This article describes studies concerning dysbiosis and probiotics in autoimmune diseases. | en |
dc.description.affiliation | Microbiology Program Institute of Biosciences Humanities and Exact Sciences, Sao Paulo | |
dc.description.affiliation | Department of Food Engineering and Technology São Paulo State University (UNESP), Sao Paulo | |
dc.description.affiliationUnesp | Department of Food Engineering and Technology São Paulo State University (UNESP), Sao Paulo | |
dc.format.extent | 545-563 | |
dc.identifier | http://dx.doi.org/10.1016/B978-0-12-819265-8.00038-3 | |
dc.identifier.citation | Comprehensive Gut Microbiota, v. 1, p. 545-563. | |
dc.identifier.doi | 10.1016/B978-0-12-819265-8.00038-3 | |
dc.identifier.scopus | 2-s2.0-85151697775 | |
dc.identifier.uri | http://hdl.handle.net/11449/247117 | |
dc.language.iso | eng | |
dc.relation.ispartof | Comprehensive Gut Microbiota | |
dc.source | Scopus | |
dc.subject | Autoimmunity | |
dc.subject | Dysbiosis | |
dc.subject | Graves' disease | |
dc.subject | Hashimoto thyroiditis | |
dc.subject | Inflammation | |
dc.subject | Microbiota | |
dc.subject | Probiotics | |
dc.subject | Rheumatoid arthritis | |
dc.subject | Sjögren syndrome | |
dc.subject | Systemic lupus erythematosus | |
dc.subject | Systemic sclerosis | |
dc.subject | Type 1 diabetes | |
dc.title | 1.39 - Intestinal Dysbiosis in Autoimmune Diseases | en |
dc.type | Capítulo de livro | |
dspace.entity.type | Publication |